Children’s Mercy Hospital Pediatric Infectious Diseases

Topics

• Respiratory viral infections research 60
• Antibiotic Use and Resistance 51
• Pneumonia and Respiratory Infections 30
• Influenza Virus Research Studies 26
• Drug-Induced Adverse Reactions 21
• HIV/AIDS Research and Interventions 19
• Antimicrobial Resistance in Staphylococcus 18
• Kawasaki Disease and Coronary Complications 15
• Vaccine Coverage and Hesitancy 14
• Antibiotics Pharmacokinetics and Efficacy 13
• Streptococcal Infections and Treatments 13
• SARS-CoV-2 detection and testing 12

Most cited

1. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19.

   JAMA · 2021 · 651 citations · Jennifer Schuster

2. Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.

   MMWR. Morbidity and mortality weekly report · 2024 · 183 citations · Jennifer Schuster

3. Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.

   JAMA pediatrics · 2025 · 64 citations · Jennifer Schuster

4. Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome.

   JAMA neurology · 2021 · 308 citations · Jennifer Schuster

5. Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children.

   JAMA pediatrics · 2026 · 25 citations · Jennifer Schuster

6. Multisystem Inflammatory Syndrome in Children - Initial Therapy and Outcomes.

   The New England journal of medicine · 2021 · 293 citations ·